Injective's INJ Token Surges Past $7.50 After Solana Listing and ETF Filing
Injective's native token INJ has surged past $7.50 in value after two significant developments on September 19, 2026. The first was the listing of INJ as a native SPL token on Solana, allowing users to trade and provide liquidity without cross-chain bridges.
The initial supply of INJ on Solana is limited to support a controlled rollout, with the broader market capitalization standing at $753.009 million and circulating supply of 100 million tokens.
The second catalyst for the surge was an S-1 update filing by 21Shares US for an Injective INJ exchange-traded fund (ETF). The proposed ETF will target to stake between 40 percent and 60 percent of its INJ holdings, with the percentage adjustable based on liquidity needs.